Stay updated on Setmelanotide in Rare Genetic Obesity: Phase 2 Clinical Trial
Sign up to get notified when there's something new on the Setmelanotide in Rare Genetic Obesity: Phase 2 Clinical Trial page.

Latest updates to the Setmelanotide in Rare Genetic Obesity: Phase 2 Clinical Trial page
- Check2 days agoChange DetectedNo additions or deletions were detected on the page based on the provided screenshot and text. The page content appears unchanged.SummaryDifference0.1%

- Check10 days agoChange DetectedAdded a consolidated Locations section listing numerous study sites (including Patras, Greece) and updated the page revision to v3.3.3. The previous separate location blocks appear to have been replaced by this consolidated listing.SummaryDifference2%

- Check17 days agoNo Change Detected
- Check24 days agoChange DetectedOnly minor formatting/text updates observed; no changes to inclusion criteria, interventions, outcomes, or locations. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check31 days agoChange DetectedRevision: v3.3.2 appears on the page, replacing Revision: v3.3.1. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check38 days agoChange DetectedPublications section now notes that items are auto-filled from PubMed and shows revision v3.3.1, replacing the previous PubMed-specific wording and the v3.2.0 label. To avoid alerts from small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check46 days agoChange DetectedNotice about government funding and NIH operating status was removed from the page. Previously, it informed users about potential delays and updates on government operations.SummaryDifference0.3%

Stay in the know with updates to Setmelanotide in Rare Genetic Obesity: Phase 2 Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Setmelanotide in Rare Genetic Obesity: Phase 2 Clinical Trial page.